ARTICLE | Company News
Ore Pharmaceuticals Inc., Roche deal
August 4, 2008 7:00 AM UTC
Under a 2005 reprofiling deal, Ore (formerly Gene Logic Inc.) exercised its option to exclusively license tiapamil from Roche to treat neurological diseases. Tiapamil had reached Phase II or III test...